Cargando…

A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial

BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Bernadette, Young, Jane, Smith, David P., Kneebone, Andrew B., Brooks, Andrew J., Egger, Sam, Xhilaga, Miranda, Dominello, Amanda, O’Connell, Dianne L., Haines, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848547/
https://www.ncbi.nlm.nih.gov/pubmed/29530071
http://dx.doi.org/10.1186/s13012-018-0733-x
_version_ 1783305891053830144
author Brown, Bernadette
Young, Jane
Smith, David P.
Kneebone, Andrew B.
Brooks, Andrew J.
Egger, Sam
Xhilaga, Miranda
Dominello, Amanda
O’Connell, Dianne L.
Haines, Mary
author_facet Brown, Bernadette
Young, Jane
Smith, David P.
Kneebone, Andrew B.
Brooks, Andrew J.
Egger, Sam
Xhilaga, Miranda
Dominello, Amanda
O’Connell, Dianne L.
Haines, Mary
author_sort Brown, Bernadette
collection PubMed
description BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia with a urological MDT and involvement in a state-wide urological clinical network participated in this pragmatic stepped wedge, cluster randomised implementation trial. Intervention strategies included flagging of high-risk patients by pathologists, clinical leadership, education, and audit and feedback of individuals’ and study Sites’ practices. The primary outcome was the proportion of patients referred to radiation oncology within 4 months after prostatectomy. Secondary outcomes were proportion of patients discussed at a MDT meeting within 4 months after surgery; proportion of patients who consulted a radiation oncologist within 6 months; and the proportion who commenced radiotherapy within 6 months. Urologists’ attitudes towards adjuvant radiotherapy were surveyed pre- and post-intervention. A process evaluation measured intervention fidelity, response to intervention components and contextual factors that impacted on implementation and sustainability. RESULTS: Records for 1071 high-risk post-RP patients operated on by 37 urologists were reviewed: 505 control-phase; and 407 intervention-phase. The proportion of patients discussed at a MDT meeting increased from 17% in the control-phase to 59% in the intervention-phase (adjusted RR = 4.32; 95% CI [2.40 to 7.75]; p < 0·001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR = 1.06; 95% CI [0.74 to 1.51]; p = 0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p = 0·001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). CONCLUSIONS: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists’ attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12611001251910). Registered 6 December 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0733-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5848547
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58485472018-03-21 A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial Brown, Bernadette Young, Jane Smith, David P. Kneebone, Andrew B. Brooks, Andrew J. Egger, Sam Xhilaga, Miranda Dominello, Amanda O’Connell, Dianne L. Haines, Mary Implement Sci Research BACKGROUND: This study assessed whether a theoretically conceptualised tailored intervention centred on multidisciplinary teams (MDTs) increased clinician referral behaviours in line with clinical practice guideline recommendations. METHODS: Nine hospital Sites in New South Wales (NSW), Australia with a urological MDT and involvement in a state-wide urological clinical network participated in this pragmatic stepped wedge, cluster randomised implementation trial. Intervention strategies included flagging of high-risk patients by pathologists, clinical leadership, education, and audit and feedback of individuals’ and study Sites’ practices. The primary outcome was the proportion of patients referred to radiation oncology within 4 months after prostatectomy. Secondary outcomes were proportion of patients discussed at a MDT meeting within 4 months after surgery; proportion of patients who consulted a radiation oncologist within 6 months; and the proportion who commenced radiotherapy within 6 months. Urologists’ attitudes towards adjuvant radiotherapy were surveyed pre- and post-intervention. A process evaluation measured intervention fidelity, response to intervention components and contextual factors that impacted on implementation and sustainability. RESULTS: Records for 1071 high-risk post-RP patients operated on by 37 urologists were reviewed: 505 control-phase; and 407 intervention-phase. The proportion of patients discussed at a MDT meeting increased from 17% in the control-phase to 59% in the intervention-phase (adjusted RR = 4.32; 95% CI [2.40 to 7.75]; p < 0·001). After adjustment, there was no significant difference in referral to radiation oncology (intervention 32% vs control 30%; adjusted RR = 1.06; 95% CI [0.74 to 1.51]; p = 0.879). Sites with the largest relative increases in the percentage of patients discussed also tended to have greater increases in referral (p = 0·001). In the intervention phase, urologists failed to provide referrals to more than half of patients whom the MDT had recommended for referral (78 of 140; 56%). CONCLUSIONS: The intervention resulted in significantly more patients being discussed by a MDT. However, the recommendations from MDTs were not uniformly recorded or followed. Although practice varied markedly between MDTs, the intervention did not result in a significant overall change in referral rates, probably reflecting a lack of change in urologists’ attitudes. Our results suggest that interventions focused on structures and processes that enable health system-level change, rather than those focused on individual-level change, are likely to have the greatest effect. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12611001251910). Registered 6 December 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-018-0733-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-12 /pmc/articles/PMC5848547/ /pubmed/29530071 http://dx.doi.org/10.1186/s13012-018-0733-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Brown, Bernadette
Young, Jane
Smith, David P.
Kneebone, Andrew B.
Brooks, Andrew J.
Egger, Sam
Xhilaga, Miranda
Dominello, Amanda
O’Connell, Dianne L.
Haines, Mary
A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title_full A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title_fullStr A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title_full_unstemmed A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title_short A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
title_sort multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: a stepped-wedge cluster randomised implementation trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848547/
https://www.ncbi.nlm.nih.gov/pubmed/29530071
http://dx.doi.org/10.1186/s13012-018-0733-x
work_keys_str_mv AT brownbernadette amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT youngjane amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT smithdavidp amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT kneeboneandrewb amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT brooksandrewj amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT eggersam amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT xhilagamiranda amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT dominelloamanda amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT oconnelldiannel amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT hainesmary amultidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT brownbernadette multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT youngjane multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT smithdavidp multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT kneeboneandrewb multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT brooksandrewj multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT eggersam multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT xhilagamiranda multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT dominelloamanda multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT oconnelldiannel multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial
AT hainesmary multidisciplinaryteamorientedinterventiontoincreaseguidelinerecommendedcareforhighriskprostatecancerasteppedwedgeclusterrandomisedimplementationtrial